Pacira BioSciences
(NASDAQ) PCRX
Pacira BioSciences Financials at a Glance
Market Cap
$926.41M
Revenue (TTM)
$726.41M
Net Income (TTM)
$7.03M
EPS (TTM)
$0.16
P/E Ratio
145.64
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Price
$22.92
Volume
13,021
Open
$23.19
Price
$22.92
Volume
13,021
Open
$23.19
Previous Close
$22.92
Daily Range
$22.74 - $23.36
52-Week Range
$18.80 - $27.64
Dividend
$0.00
Beta (Volatility)
0.59 (Low)
Price
$22.92
Volume
13,021
Open
$23.19
Previous Close
$22.92
Daily Range
$22.74 - $23.36
52-Week Range
$18.80 - $27.64
PCRX News
PCRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pacira BioSciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
829
CEO
Frank D. Lee, MBA
Website
www.pacira.comHeadquarters
Tampa, FL 33609, US
PCRX Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
3%
Net Income Margin
1%
Return on Equity
96%
Return on Capital
2%
Return on Assets
1%
Earnings Yield
0.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$926.41M
Shares Outstanding
40.49M
Volume
13.02K
Short Interest
0.00%
Avg. Volume
900.08K
Financials (TTM)
Gross Profit
$519.37M
Operating Income
$28.10M
EBITDA
$119.13M
Operating Cash Flow
$151.99M
Capital Expenditure
$15.33M
Free Cash Flow
$136.66M
Cash & ST Invst.
$238.42M
Total Debt
$454.38M
Pacira BioSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$196.87M
+5.1%
Gross Profit
$142.25M
-3.5%
Gross Margin
72.26%
N/A
Market Cap
$926.41M
N/A
Market Cap/Employee
$1.18M
N/A
Employees
788
N/A
Net Income
$1.64M
-89.8%
EBITDA
$24.53M
-51.5%
Quarterly Fundamentals
Net Cash
$215.96M
-40.0%
Accounts Receivable
$124.07M
+9.5%
Inventory
$152.86M
+22.0%
Long Term Debt
$444.54M
+3.8%
Short Term Debt
$9.84M
-95.3%
Return on Assets
0.56%
N/A
Return on Invested Capital
1.75%
N/A
Free Cash Flow
$43.47M
+40.2%
Operating Cash Flow
$43.69M
+31.9%